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ABSTRACT
Introduction: Livestock husbandry is critical for food security and poverty reduction in a low-
income country like Tanzania. Infectious disease is one of the major constraints reducing the
productivity in this sector. Peste des petits ruminants (PPR) is one of the most important
diseases affecting small ruminants, but other infectious diseases may also be present.
Objective: The objective of this study was to determine the seroprevalence and risk factors
for exposure to PPR, contagious caprine pleuropneumonia (CCPP), foot-and-mouth disease
(FMD), bluetongue (BT), and bovine viral diarrhoea (BVD) in sheep and goats in Tanzania.
Methods: Serum samples were collected in 2014 and 2015, and analysed using enzyme-
linked immunosorbent assays to detect antibodies to the five pathogens.
Results and discussion: This is the first description of seroprevalence of FMD and BT among
small ruminants in Tanzania. Risk factor analysis identified sex (female) (OR for 2014: PPR: 2.49,
CCPP: 3.11, FMD: 2.98, BT: 12.4, OR for 2015: PPR: 14.1, CCPP: 1.10, FMD: 2.67, BT: 1.90, BVD:
4.73) and increasing age (>2 years) (OR for 2014: PPR: 14.9, CCPP: 2.34, FMD: 7.52, BT: 126, OR
for 2015: PPR: 8.13, CCPP: 1.11, FMD: 2.98, BT: 7.83, BVD: 4.74) as risk factors for exposure to
these diseases.
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Introduction
Small ruminants play an important role in food
security and livelihood resilience in many parts of
the world [1], but there are several constraints redu-
cing the productivity in this sector [2,3]. Infectious
disease is considered a major restriction causing
direct losses, such as death and decreased production,
and indirect losses, such as export constraints [3].
Peste des petits ruminants (PPR) is one of the most
important diseases affecting small ruminants world-
wide [4,5]. PPR is caused by peste des petits ruminants
virus (PPRV), a highly contagious virus that gives rise
to disease in sheep, goats, and camels and has also
been reported in wild ruminants [6]. Clinical signs of
PPR include pyrexia (40–41°C), ocular and nasal dis-
charges, lesions in the oral and nasal mucus mem-
branes, dyspnoea, cough, pneumonia, diarrhoea, and
severe dehydration [7]. Morbidity and case fatality
rates vary and, depending on factors such as immune
status, age, species, and presence of other co-infec-
tions, they can be as high as 90–100% [8].
Clinical presentation of PPR can be difficult to
differentiate from other diseases affecting small
ruminants [7]. Differential diagnoses include
contagious caprine pleuropneumonia (CCPP), foot-
and-mouth disease (FMD), and bluetongue (BT) [9].
CCPP is caused by the bacterium Mycoplasma capri-
colum subsp. capripneumoniae (Mccp) [10], FMD is
caused by foot-and-mouth disease virus (FMDV)
[11], and BT is caused by bluetongue virus (BTV)
and is spread by the vector Culicoides mosquitos
[12]. Infection with bovine viral diarrhoea virus
(BVDV), or the closely related border disease virus
(BDV), is generally not considered a differential
diagnosis of PPR as these viruses mostly cause
reproductive disease in small ruminants [13–15].
However, co-infections with PPRV and BVDV,
BDV, or BTV are believed to exacerbate the clinical
signs of PPR [16,17].
PPR, CCPP, FMD, and BT are among the 10 most
important diseases in sheep and goats worldwide in
terms of lost livestock units [5]. For PPR, 6 of the 10
most affected countries during 2006–2009 were
African countries [5]. Tanzania, located on the east
coast of Africa, is a low-income country with 28.2%
of the population living below the national poverty
line [18]. Of the total population, 68.4% live in rural
areas and three of five rural households earn, on
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average, 22% of their income from livestock husban-
dry [19]. Poorer households tend to keep small live-
stock, such as chicken, sheep and goats, whereas
wealthier households keep large livestock [19]. Small
ruminants are kept by 52% of Tanzanian households,
with an estimated number of 15 million goats and 6
million sheep [20]. PPR was first confirmed in
Tanzania in 2008 [21], but a retrospective study on
samples collected in the northern districts found anti-
bodies to PPRV were probably already present in
2004 [22]. The disease has since spread to the south-
ern parts of the country and is now considered ende-
mic in the domestic, small ruminant population in
the whole country [23–25]. CCPP, FMD, BT, and
BVD are endemic in Tanzania [24], however studies
on FMD and BT have only been performed on large
ruminants.
All of the diseases in question (PPR, CCPP, FMD,
BT, and BVD) have been described in wildlife [26–
30]. Wild ruminants have been shown to carry PPRV
and several species can develop clinical signs of PPR
[28,31,32]. Whether interaction or proximity between
livestock and wildlife in general, and wild ruminants
in particular, is an important risk factor for exposure
to PPRV has not yet been determined.
The objective of this study was to estimate the ser-
oprevalence of, and determine possible risk factors for
exposure to, PPR, CCPP, FMD, BT, and BVD in small
domestic ruminants in selected areas of Tanzania.
Materials and methods
Study area and study design
This study was carried out with the aim to under-
stand the epidemiology of PPR at the wildlife–live-
stock interface in Tanzania. Thus, the study area was
in parts of the country with such an interface (shared
pastures, shared water, and regular proximity) and in
regions where PPR had previously been described
[21,33]. Tanzania is divided into 26 administrative
regions, subdivided into districts, and further into
wards [34]. Four districts were purposively selected
for this study: Ngorongoro in the northern Arusha
region, and Ulanga, Kilombero, and Mvomero in the
south-eastern Morogoro region (Figure 1). Wards in
Figure 1. Geographical map of sampling area. Striped green areas indicate visited districts (1 = Ngorongoro, 2 = Mvomero,
3 = Kilombero, 4 = Ulanga). Striped red areas indicate parks or game reserves, i.e. areas with a higher concentration of wildlife
(A = Ngorongoro Conservation Area, including Ngorongoro National Park, B = Mikumi National Park, C = Selous Game Reserve).
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the districts, located outside, bordering, or within
parks or reserves (with a wildlife–livestock interface)
were purposively selected, after which 50% were then
randomly assigned to the study. In collaboration with
local extension officers, wards were replaced with
neighbouring wards when those selected did not
have enough animals or were inaccessible.
A confidence interval of 95%, a margin of error of
5%, an infinite population, an assumed true overall
prevalence of 50% to obtain maximum sample size,
and the sensitivity (94.5%) and specificity (99.4%) of
the PPR competitive enzyme-linked immunosorbent
assay (cELISA) [35] were used [36,37] in calculations
of the sample size (PPR cELISA was used to calculate
sample size as PPR was the main focus of the study).
This gave the needed sample size of 435 samples for
each of the two years when herds (containing sheep
and/or goats) were visited. To reach the estimated
sample size and to assure an even dispersion of the
samples in the selected area, we aimed to sample 3
villages in each ward, 2–3 herds per village and 12–20
animals per herd, depending on herd size. If herds
were smaller than 12 animals, all of the animals in the
herd were sampled.
The study was conducted during two successive
years: 2014 (Ngorongoro, Mvomero, and Ulanga)
and 2015 (Ulanga and Kilombero). No herd was
visited and sampled in both 2014 and 2015. Animals
of all ages (2014) were sampled as previously
described [38]. However, according to the interview
study from this first visit, 43.7% of the sampled
animals had been vaccinated against PPRV, possibly
resulting in biased prevalence estimates. Therefore, in
2015, young animals (3–12 months) were selected to
avoid false positive results due to vaccination or
maternal antibodies. If herds did not include enough
animals within this age range, older animals were
sampled to reach the goal of 12–20 animals per herd.
Ethical consideration
Sampling was done in collaboration with Tanzania
District Veterinary Office, and a local veterinarian or
veterinary assistant was present at all sampling sites.
Ethical approval was sought and received from the
Swedish University of Agricultural Sciences Research
Animal Council (SLU ua 2017.1.1.1–1881).
Sample and data collection
Herds of pastoralists or traditional farmers were vis-
ited during September–October 2014 and June–July
2015. Oral consent to sample animals was obtained
from the herd owners prior to sample collection.
Blood was collected from the jugular vein using ster-
ile needles and vacutainer tubes without additives
(BD vacutainer, Plymouth, UK). Blood samples were
left to coagulate and separate in a vertical position in
a cool box. After separation, the serum was trans-
ferred to 2-ml cryotubes and stored at −45°C until
analysis.
A pre-prepared questionnaire in English was
used for epidemiological data collection at the sam-
pling sites. Interviews were performed in Swahili by
a local translator. The questionnaires differed
between the two years, due to preliminary results
from 2014 and extension of the study for the sam-
ple collection in 2015. The 2014 questionnaire
included open-ended questions regarding the size
of herd, type of animals in the herd, if and when
animals were vaccinated against PPR, if the animals
interacted with wildlife, and if so, which wildlife
species. Interaction with wildlife was specified as
physical proximity or shared pastures. The 2015
questionnaire was modified to include information
about vaccinations against PPR, CCPP, and FMD,
and interaction of the herd with other domestic
herds of sheep, goats, or cattle and wildlife. This
questionnaire included open-ended questions
regarding size of the herd, type of animals in it, if
and when animals were vaccinated against PPR,
CCPP, and FMD, how often the herd interacted
with other domestic herds, latest introduction of
new animals into the herd, and how often the
herd interacted with wildlife.
Laboratory analysis
Commercial enzyme-linked immunosorbent assay
(ELISA) kits were used to analyse the presence of
antibodies to the selected pathogens: ID screen PPR
competition ELISA (detects anti-PPRV nucleoprotein
antibodies [35], sensitivity 94.5%, specificity 99.4%;
ID. Vet, Grabels, France), IDEXX CCPP Ab test (uses
monoclonal antibody ‘4.52’ against Mycoplasma sp.
Type F38 [39], no information for sensitivity, speci-
ficity 99.6%; IDEXX, Hoofddorp, The Netherlands),
ID screen FMD NSP competition (detects anti-FMDV
3ABC non-structural protein antibodies, sensitivity
100%, specificity 99.4%; ID. Vet, Grabels, France),
Bluetongue Virus (BTV) Antibody Test Kit (detects
anti-BTV VP7 protein antibodies, sensitivity 83%,
specificity 100%; IDEXX, Hoofddorp, The
Netherlands), and BVDV p80 Ab Test Kit (detects
anti-BVDV p80 antibodies sensitivity 100%, specifi-
city 99.2%; IDEXX, Hoofddorp, The Netherlands).
The BVDV p80 Ab Test Kit detects antibodies to
both BVDV and BDV, without the ability to differ-
entiate between the two. All kits were used and inter-
preted according to the manufacturers’ instructions.
For PPR, BT, and BVD, there were three different
outcomes for the ELISA: positive, negative, or doubt-
ful. In the statistical analysis a doubtful result was
considered as negative.
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Statistical analysis
The true prevalence was calculated based on the
apparent prevalence and the sensitivity and specificity
of the diagnostic tests used, in accordance with [40].
Individual animal results were analysed for possible
risk factors for seropositivity, as an indirect measure
of exposure: sex, species, age group, and, in the case
of PPR and CCPP, vaccination was also included in
the analysis, given that the diagnostic test used could
not differentiate between infected and vaccinated ani-
mals. Age of animal and date of when vaccination
had been performed according to the owners were
taken into consideration when classifying animals as
vaccinated or not. A confidence interval (95%) for the
positive proportion was calculated using the score
method with continuity correction [41]. To minimize
vaccination as a confounder, the animals that owners
reported to be vaccinated were excluded from the
results in the univariable analysis. All statistical ana-
lyses were performed in R, Version 3.2.2 [42], and
each of the pathogens was analysed separately.
Association between risk factors and outcome (i.e.
seropositivity to one of the pathogens) was analysed
using the command oddsratio from the fmsb package,
with corrections for difference in proportions. A
p-value < .05 was considered as significant. Risk fac-
tors with a p-value < .2 in the univariable analysis
were analysed in a generalized linear mixed-effect
model, using the glmer command from the lme4
package [43]. Risk factors were included as fixed
effects, and herd was included as a random effect to
account for potential clustering. At herd level in 2014,
the risk factors included the district and whether
owners reported their animals being in proximity to
wildlife, whereas in 2015 they included district,
reports of proximity to wildlife, interaction with
other domestic herds, and introduction of new ani-
mals in the last 12 months. The proportion of posi-
tive animals in herds and all risk factors were added
to the generalized linear mixed-effect model without
previous univaribale analysis. Again, herd was
included as a random effect. Interactions between
risk factors were tested for in all models.
Results
Descriptive analysis
Of 957 animals, 476 animals (from 39 different herds)
were sampled in 2014 and 481 animals (from 46
different herds) in 2015. In 2014, 50% of the animals
were goats and in 2015 67.2% of the animals were
goats. The remainder were sheep. The sex distribu-
tion was 73.5% female (including both goats and
sheep) in 2014 and 64.9% were female in 2015. In
2014, 17.9% of sampled animals were < 1 year (52.3%
females), 26.1% were 1–2 years (58.9% females), and
56% were > 2 years (87.1% females). In 2015, the age
distribution was: 53.3% < 1 year (54.3% females),
26.4% 1–2 years (71.4% females), and 20.1% >
2 years (83.3% females).
Seroprevalence
Antibodies to the pathogens were detected in all
visited districts, with some exceptions. BVDV was
not detected in the 2014 Ulanga samples, nor was
CCPP detected either year in this district. No samples
from Ngorongoro were analysed for BT or BVD.
The true prevalence for PPR was estimated at
49.3% (95% CI 44.5;54.0) in 2014 and 10.0% (95%
CI 7.1;12.8) in 2015. The true prevalence of FMD was
39.0% (95% CI 33.8;44.3) in 2014 and 14.1% (95% CI
10.9;17.2) in 2015. The highest seroprevalence was for
BT for both years: 98.9% (95% CI 90.1;100) in 2014
and 74.5 % (95% CI 68.4;80.6) in 2015. The lowest
was for BVD: 3.9% (95% CI 0;8.0) in 2014 and 1.7%
(95% CI 0.1;3.4) in 2015. It was not possible to
calculate the true prevalence of CCPP because there
was no information for sensitivity of the ELISA kit
[44]. Observed prevalence for the pathogens is given
in Tables 1 and 2.
Risk factor analysis
Univariable analysis showed a significant difference
between male and female animals, with females at
higher risk of being seropositive for the tested
pathogens, except BVD and CCPP in 2015 (Tables
3-7). Goats were found to be at higher risk than the
sheep for seropositivity against CCPP in both years
(OR 57.2 in 2014 and OR 9.68 in 2015), and FMD
(OR 1.94) and BT (OR 1.64) in 2015 (Tables 4-6).
Multivariate analysis identified sex (female) as a
significant risk factor for all pathogens, except
CCPP and BT in 2015 (Tables 3-7). Increased ser-
opositivity in animals older than 2 years was signifi-
cant for all pathogens in both years, except for
CCPP in 2015.
Analysis at herd level showed a significant asso-
ciation between the Mvomero region (visited in
2014) and seropositivity for PPR and FMD. For
FMD, an association with the region Kilombero
was significant in 2015 (Tables 3 and 5).
Proximity to wildlife was not identified as a risk
factor for any of the pathogens for either of the
years (Tables 3-7). Rather, proximity to wildlife was
identified in 2015 to have a negative association
with seropositivity for CCPP. Interaction with
other domestic herds was identified to have the
same association for CCPP (Table 4). Interaction
with other domestic herds was a significant risk
factor for being seropositive for FMD and BT in
2015 (Tables 5 and 6).
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An interaction was found between the variables
age group and vaccination against PPR in the samples
from 2014. Effect of vaccination against PPR differed
among the age groups.
Discussion
In this study, we investigated the seroprevalence of
PPR and some of its differential diagnoses in selected
areas in Tanzania. Commercial ELISA tests were used
to detect antibodies in serum samples from sheep and
goats. The serological results were used further to
calculate risk factors for exposure to PPRV, Mccp,
FMDV, BTV, and BVDV. In Tanzania, and other east
African countries, small ruminant production is an
important livelihood for a significant proportion of
the population [19]. This important position of small
ruminants is one of the reasons behind the joint Food
and Agriculture Organization (FAO) and World
Organization for Animal Health programme to con-
trol and eradicate PPR and control small ruminant
diseases [4]. PPRV is quickly increasing its spread
Table 3. Univariable and multivariable analyses for risk factors associated with PPR seropositivity at individual animal level and
herd level.
Univariable
2014 2015
OR 95% CI p-Value OR 95% CI p-Value
Sex Male 2.49 1.37;4.54 .002 Male 14.1 1.87;106 <.001
Female Female
Species Sheep 1.01 0.60;1.70 .964 Sheep 1.38 0.49;3.88 .535
Goat Goat
Vaccination No 3.30 2.25;4.85 <.001 No 5.12 2.69;10.0 <.001
Yes Yes
Age group < 1 year Baseline <.001 < 1 year Baseline <.001
1–2 years 1.12 0.56;2.29 1–2 years 3.98 1.70;9.27
> 2 years 14.9 8.10;27.5 > 2 years 8.13 3.59;18.4
Multivariate
Sex Male Baseline .002 Male Baseline .006
Female 2.78 1.48;5.40 Female 6.18 1.95;28.2
Vaccination No Baseline .774
Yes 1.22 0.31;4.93
Age group < 1 year Baseline
1–2 years 3.51 1.11;12.4 .037
> 2 years 17.6 3.78;113 <.001
Vaccination *Age group Yes*< 1 year 5.14 1.43;19.3 .010
Yes*1–2 years – – –
Yes*> 2 years 0.86 0.08;10.2 .010
Herd level
District Ulanga Baseline Kilombero Baseline
Mvomero 4.68 2.34;10.5 <.001 Ulanga 1.10 0.33;3.72 .874
Ngorongoro 2.21 0.74;7.27 .155
Interaction with wildlife 0.59 0.21;1.59 .285 Interaction with wildlife 0.94 0.29;2.75 .910
Interaction with domestic herds 1.65 0.42;7.71 .476
Introduction of new animals 1.24 0.31;4.90 .740
Serological results from a repeated cross-sectional study of small ruminants carried out in Tanzania. Factors with p < .2 in univariabale analysis were
used in multivariate analysis. p-Values <.05 were considered significant and are in bold. Interaction between vaccination and age group in samples
from 2014 are marked with *.
Table 4. Univariable and multivariable analyses for risk factors associated with CCPP seropositivity at individual animal level and
herd level.
Univariable
2014 2015
OR 95% CI p-Value OR 95% CI p-Value
Sex Male 3.11 1.22;7.60 .010 Male 1.10 0.62;1.95 .740
Female Female
Species Sheep 57.2 7.78;420 <.001 Sheep 9.68 2.96;31.7 <.001
Goat Goat
Age group < 2 years 2.34 1.18;4.63 .013 < 1 year Baseline .801
> 2 years 1–2 years 1.24 0.66;2.33
> 2 years 1.11 0.54;2.28
Multivariate
Sex Male Baseline .029
Female 4.46 1.24;19.0
Species Sheep Baseline – <.001 Sheep Baseline .021
Goat 81.9 17.4;726 Goat 9.21 1.70;84.0
Age group < 2 years Baseline – .012
> 2 years 5.17 1.54;21.1
Herd level
Interaction with wildlife 0.60 0.06;4.44 .598 Interaction with wildlife 0.008 <0.01;0.16 .006
Interaction with domestic herds 0.045 <0.01;0.48 .016
Introduction of new animals 4.24 0.14;303 .414
Serological results from a repeated cross-sectional study of small ruminants carried out in Tanzania. Factors with p < .2 in univariabale analysis were
used in multivariate analysis. p-Values <.05 were considered significant and are in bold text.
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Table 6. Univariable and multivariable analyses for risk factors associated with BT seropositivity at individual animal level and
herd level.
Univariable
2014 2015
OR 95% CI p-Value OR 95% CI p-Value
Sex Male 12.4 3.90;39.5 <.001 Male 1.90 1.22;2.95 .004
Female Female
Species Sheep 1.39 0.50;3.88 .527 Sheep 1.64 1.02;2.64 .040
Goat Goat
Age group < 1 year Baseline <.001 < 1 year Baseline <.001
1–2 years 2.62 0.65;10.5 1–2 years 2.42 1.44;4.07
> 2 years 126 13.9;1153 > 2 years 7.83 3.68;16.7
Multivariate
Sex Male Baseline – .030 Male Baseline .437
Female 7.49 1.29;63.9 Female 1.26 0.70;2.27
Species Sheep Baseline .023
Goat 2.32 1.14;4.93
Age group < 1 year Baseline – – < 1 year Baseline
1–2 years 3.34 0.42;155 .319 1–2 years 3.04 1.53;6.32 .002
> 2 years 183 15.2;23,216 .001 > 2 years 18.4 6.61;61.4 <.001
Herd level
District Ulanga Baseline .356
Mvomero 2.42 0.30;21.9
Interaction with wildlife 0.57 0.03;7.61 .636 Interaction with wildlife 1.18 0.48;2.94 .698
Interaction with domestic herds 3.85 1.55;10.5 .004
Introduction of new animals 0.99 0.26;3.65 .983
Serological results from a repeated cross-sectional study of small ruminants carried out in Tanzania. Factors with p < .2 in univariabale analysis were
used in multivariate analysis. p-Values <.05 were considered significant and are in bold text.
Table 5. Univariable and multivariable analysis for risk factors associated with FMD seropositivity at individual animal level and
herd level.
Univariable
2014 2015
OR 95% CI p-Value OR 95% CI p-Value
Sex Male 2.98 1.63;5.45 <.001 Male 2.67 1.41;5.03 .002
Female Female
Species Sheep 1.47 0.95;2.27 .086 Sheep 1.94 1.06;3.56 .030
Goat Goat
Age group < 1 year Baseline <.001 < 1 year Baseline <.001
1–2 years 1.51 0.58;3.93 1–2 years 0.86 0.43:1.72
> 2 years 7.52 3.40;16.6 > 2 years 2.98 1.66;5.35
Multivariate
Sex Male Baseline .003 Male Baseline .001
Female 3.77 1.58;9.48 Female 4.70 1.91;13.1
Species Sheep Baseline – .099 Sheep Baseline .008
Goat 1.81 0.90;3.68 Goat 4.19 1.54;13.0
Age group < 1 year Baseline < 1 year Baseline
1–2 years 1.51 0.4;5.56 .534 1–2 years 1.21 0.46;3.20 .698
> 2 years 8.73 2.82;30.5 <.001 > 2 years 9.10 3.10;30.8 <.001
Herd level
District Ulanga Baseline Ulanga Baseline .044
Mvomero 25.1 11.1;73.8 <.001 Kilombero 6.15 1.02;44.7
Ngorongoro 2.36 0.43;12.2 .298
Interaction with wildlife 1.13 0.36;3.47 .816 Interaction with wildlife 1.52 0.28;8.97 .612
Interaction with domestic herds 20.7 3.10;262 .005
Introduction of new animals 0.13 0.01;1.18 .067
Serological results from a repeated cross-sectional study of small ruminants carried out in Tanzania. Factors with p < .2 in univariabale analysis were
used in multivariate analysis. p-Values <.05 were considered significant and are in bold text.
Table 7. Univariable analysis for risk factor associated with BVD seropositivity at individual animal level.
Univariable
2014 2015
OR 95% CI p-Value OR 95% CI p-Value
Sex Male – – .150 Male 4.73 0.58;38.2 .110
Female Female
Species Sheep 2.02 0.32;12.6 .445 Sheep 0.46 0.12;1.73 .239
Goat Goat
Age group < 1 year – – .279 < 1 year Baseline .023
1–2 years 1–2 years 0.65 0.07;6.33
> 2 years > 2 years 4.74 1.10;20.4
Serological results from a repeated cross-sectional study of small ruminants carried out in Tanzania. There were no positive male animals or age groups
<1 and 1–2 years in samples from 2014, so it was not possible to obtain OR for the risk factor ‘age group’ or ‘sex’. Multivariate analysis was not
possible due to an insufficient number of seropositive animals. p-Values <.05 were considered significant and are in bold text.
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across the world and is now threatening the most
southern countries of Africa, with Tanzania currently
being its southern border on the east coast [25]. To
stop the spread further south, it is important to
understand the prevalence and epidemiology of both
PPR and its most common differential diagnosis, as
the clinical presentation can be difficult to diag-
nose [4].
The calculated true seroprevalence for PPR was
49.3% in 2014 and 10.0% in 2015. A vaccination
campaign had been carried out in the Morogoro
and Mtwara region prior to our sample collection
[45], which may have influenced the 2014 results.
Therefore, we aimed to sample animals aged
3–12 months in 2015, as animals in this age group
would not have been alive during the vaccination
campaign. As expected for an endemic disease,
where survival of infection results in lifelong immu-
nity, age was identified as a risk factor for exposure
(Table 3). Age and vaccination bias of sampled ani-
mals could be the reasons for the difference in ser-
oprevalence in 2014 and 2015. In addition, we did not
visit the same areas both years; the differences in
seroprevalence could therefore have been due to geo-
graphical differences. Previous studies in northern
Tanzania found an overall seroprevalence of 45.5%
in 2008 [46] and 22.1% in 2008–2009 [21]. In south-
ern Tanzania, in the Mtwara region bordering
Mozambique, 31% of sampled small ruminants had
antibodies to PPRV [47]. A recent study analysing
samples from 14 different regions of Tanzania
described an overall seroprevalence of 27.1%, with
regions varying from 2.4% (Kagera) to 72.8%
(Morogoro), demonstrating the varying level of ser-
oprevalence within the country [23].
Sex has previously been described as a risk factor
for PPR; mostly females are identified to be at higher
risk [21,48,49]. However, some studies found the
opposite association [50–52]. Our results suggest that
females had a higher risk of being seropositive for
PPRV in both 2014 and 2015. Previous studies on
risk factors for PPR have suggested that females are
kept longer by their owners (to be used in reproduc-
tion), and therefore have a longer risk period for
PPRV exposure [48]. In addition, females are more
likely to be vaccinated, which may bias the results. The
stress associated with pregnancy and milk production
may also predispose females to infection [48,49].
Differences between the studies, such as management
systems or breed of sheep and goats, may also influ-
ence the results. In our study, we found that the age
group >2 years was mainly composed of females. This
age group had the highest proportion of seropositive
individuals; the result might be due to a selection bias.
However, the multivariable analysis did not find an
interaction between these two variables, indicating that
this cannot be the entire explanation.
The true prevalence for CCPP was not possible to
calculate because there was no available information
on sensitivity for the ELISA test used [44]; however,
the apparent prevalence was 14.6% in 2014 and 18.8%
in 2015. Previously, a prevalence of 51.2% (in 2007)
and 33.7% (in 2009) had been described in southern
Tanzania [51].
Goats were identified to be at higher risk than
sheep for seropositivity towards CCPP in both
years, due to CCPP having a higher affinity for
goats. Sheep can develop clinical signs following
infection by CCPP, but the infection can also be
subclinical [53].
The calculated true prevalence for FMD was 39.0%
in 2014 and 14.1% in 2015 for both sheep and goats.
To the best of our knowledge, no previous reports of
seroprevalence of FMD in small ruminants in
Tanzania are available. FMDV causes a less severe
disease in small ruminants compared with large
ruminants [54]; however, the oral lesions sometimes
seen even in small ruminants make FMD an impor-
tant differential diagnosis of PPR, especially in light
of the attempt to eradicate PPR [7]. A study in
neighbouring Uganda found a seroprevalence of
14% in goats and 22% in sheep [55]. Seroprevalence
of FMD in buffalo and cattle in Tanzania is high.
Mkama et al. [56] found an overall prevalence of
76.3% (248 of 330) for buffalo and cattle, with the
buffalos from western Tanzania having a 100% ser-
oprevalence (29 of 29). Antibodies to FMDV decrease
faster in sheep than cattle [57], which could be one
explanation for the difference in seroprevalence
between small and large ruminants. As for PPR, our
study identified age as a risk factor for FMDV expo-
sure. Age is a documented risk factor for FMDV
exposure in cattle, both in endemic and epidemic
settings [58,59]. A higher age gives a longer time to
be exposed in the endemic setting, and the higher
mortality seen in younger animals leaves the older
seropositive animals to be sampled [59,60]. Also in
line with the results for PPR, female animals were
identified to be at a higher risk than males for FMDV
exposure. Similar explanations in PPR can be applied
to FMD as well, with the exception of vaccination.
None of the owners reported that their animals had
been vaccinated against FMD.
The calculated true prevalence for BT was 98.9% in
2014 and 74.5% in 2015. No previous studies have
been done on seroprevalence of BT in domestic ani-
mals in Tanzania. As with FMD, possible oral lesions
caused by BTV makes it an important differential
diagnosis of PPR [12]. Free-living wild buffalos
from eight different areas in Tanzania were sampled
between 1987 and 1989 and analysed for antibodies
to a selection of pathogens, including BT [61]. An
overall prevalence of 91.6% was found, with six of
eight areas having a 100% prevalence [61]. A similar
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study was performed on wildlife in Zimbabwe with
samples collected between 1989 and 1995 [62]. Most
samples came from buffaloes, followed by different
species of antelopes, and also white and black rhino-
ceroses. An overall prevalence of antibodies to BTV
of 44.1% was found [62]. Domestic cattle were
sampled in western Sudan and serological evidence
of BTV infection was found in 19.4% of them (58 of
299) [63]. Our results are more in line with those
from [59] and [60]. A high seroprevalence is expected
from a virus that often gives a subclinical or unap-
parent disease in ruminants and is spread very effi-
ciently by its vector [12]. Risk factors identified for
exposure to BTV included age and sex (Table 6), as
for the other pathogens in this study. Age as a risk
factor for exposure to BTV is in agreement with a risk
factor analysis in cattle in western Sudan [63]. In
2015, multivariate analysis identified goats as being
at higher risk for exposure to BTV than sheep. In
2015, 73% of samples analysed came from goats,
which may have biased the result.
The calculated true prevalence for BVD was 3.9%
in 2014 and 1.7% in 2015. This is lower than what has
previously been described for domestic animals in
Tanzania. In Tanzanian samples collected between
1985 and 1987 from cattle, sheep, and goats, evidence
of BVD exposure was described in 34.0% of cattle,
32.1% of sheep, and 24.9% of goats [64]. In wild
buffaloes, mainly from northern parts of Tanzania,
16.9% had antibodies to BVDV [61]. Five cattle herds
in the Kafue flats of Zambia were tested for antibo-
dies to a selection of pathogens, and 76.2% were
positive for BVDV [65]. A more recent study was
performed in western Kenya; calves aged 3–7 days
were tested for antibodies to BVDV and an adjusted
seroprevalence of 19.8% was identified [66].
Seroprevalence for BVD varies significantly between
the different studies, with our study having the lowest
prevalence. Dissimilarities in the studies include dif-
ferences in production of animals sampled, method
of analysis, year of sampling, and study design, which
makes comparisons difficult. Univariable analysis of
our serological results from 2015 identified age (>
2 years) as a risk factor for exposure to BVD.
Because of the low number of seropositive animals
(9 out of 357), further studies are warranted before
making any definite conclusions on risk factors for
exposure. Multivariate analysis could not be per-
formed with the BVD results due to too few positive
samples.
Correlation between seropositivity for the studied
pathogens, except BVD, was analysed at herd level; a
generalized linear mixed-effect model was used to
identify risk factors affecting the entire herd. In this
study no difference was found, for any of the patho-
gens, between herds with proximity to wildlife and
those without. PPRV has long been known to cause
disease in wildlife [28]. Clinical signs are yet to be
described in wild ruminants in sub-Saharan Africa,
but have been reported in wild ruminants in Asia and
in the Middle East [67]. Antibodies have been
described in wild buffaloes, Grant’s gazelle, wildebe-
est, and impala in Tanzania [32,68]. Recently, a
Grant’s gazelle without clinical signs of PPR in north-
ern Tanzania tested positive on real-time reverse
transcription polymerase chain reaction [32]. The
gazelle was sampled in an area with an ongoing out-
break of PPR among domestic animals. The same
study found a 63% seroprevalence in 46 sampled
wild ruminants [32]. Although it is probable that
PPR transmits between domestic and wild animals
[32,69,70], our results do not support the hypothesis
of wildlife as an important risk factor for exposure for
domestic animals in an endemic setting. For the
closely related rinderpest virus, the well-accepted
hypothesis was that infection in wildlife was not
self-sustaining, but rather a case of spillover from
domestic animals [71,72]. The same hypothesis has
been suggested for PPRV [32,73], and our results
seem to be in agreement with this.
For FMD, contact with wildlife has been described
as an important risk factor for infection in domestic
animals in sub-Saharan Africa [74]. However, among
wildlife species, only the African buffalo has been
identified as a long-term maintenance host [74].
Small ruminants are highly susceptible to FMDV
infection, but they are not as efficient as cattle in
maintaining the infection within the population
[11]. Years of experience with FMD in southern
Africa have been unable to reveal small ruminants
as an important part of the maintenance or transmis-
sion of the disease [75]. Our results did not identify
proximity to wildlife as a risk factor for FMD in
domestic small ruminants in these areas of Tanzania.
Bluetongue virus is endemic in both the domestic
and wild populations of many African countries [12].
Various wildlife species, both in Africa and in
Europe, have been discussed as possible reservoirs
[62,76,77]. The epidemiology of BTV differs from
the other viruses studied here, as it is spread through
its vector, the Culicoides mosquito, not through direct
contact. In parts of Europe where BT is endemic,
studies suggest that wild ruminants, mainly red
deer, play a role in the epidemiology [76]. Our results
did not indicate proximity to wildlife as an important
risk factor for small ruminants to be exposed to BTV
in the studied area. However, we did identify inter-
action with other domestic herds as a risk factor, in
agreement with a previous study of sheep and goats
in Iran [78]. Possibly the vector is attracted by the
increased number of animals in the same location.
For CCPP in 2015, proximity to wildlife had a
statistically significant negative association, as did
interaction with other domestic herds (Table 4). The
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ELISA used for detection of CCPP is specific for
antibodies against Mccp [44]; however, cross-protec-
tion between different subspecies of mycoplasmas
cannot be excluded [53,79,80]. It is possible that
other members of the Mycoplasma mycoides cluster
are circulating in the studied areas and producing
cross-protection against CCPP.
Limitations of this study include none of the
ELISAs used being able to differentiate between
vaccinated and naturally infected animals, and all
questionnaire data being collected by a local trans-
lator. Information regarding vaccination status of
the animals was acquired from the owners.
Owners could, for a variety of reasons, provide
incorrect information; for example, they do not
remember, or a previous owner had the animals
vaccinated. To minimize this bias during the sample
collection in 2015, we targeted animals
3–12 months of age, animals the owners were
more likely to have the correct information about.
Further, we used the information from the ques-
tionnaires to study whether interaction with wildlife
was a possible risk factor for exposure to the stu-
died pathogens. Owners were asked how often the
animals had contact with wildlife. The question
could, however, have been misunderstood or inter-
preted in a different way than what we intended.
Answers given to the question were, for example:
‘never’, ‘during dry season’, and ‘everyday’. The
interaction between wildlife and livestock can be
measured using several methods, with the usage of
a questionnaire and local knowledge being a fast
and practical method to get preliminary data [81].
The method is not, however, as precise as others,
and this insecurity should be considered when
interpreting the results of the risk factor analysis.
Conclusion
This study confirmed the presence of antibodies to
PPRV, CCPP, FMDV, BTV, and BVDV in sheep and
goats in northern and south-eastern Tanzania, indi-
cating a continuous circulation of these pathogens.
This is the first description of the presence of anti-
bodies for FMD and BT in small ruminants in
Tanzania. Risk factor analysis at individual animal
level identified sex (female) and increasing age as
two important factors influencing level of exposure
to infection. Proximity to wildlife was not identified
as a risk factor for any of the pathogens studied.
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